Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-09-26, Stock:NVS, The news for the past five days is as follows:
2019-09-19: NEWS1: Biogen's New Study to Test Higher Dose of SMA Drug Spinraza.NEWS2: Novartis has halted distribution of generic Zantac. Here's what you need to know..NEWS3: The Daily Biotech Pulse: China Biologics Receives Buyout Offer, Provention Bio Offering, Exagen IPO.NEWS4: British baby's death not due to SMA gene therapy -- Novartis.
2019-09-20: NEWS1: Pharma Stock Roundup: FDA Approves Expanded Use of MRK/J&J's Drugs & Other Updates.
2019-09-23: NEWS1: Investors May Want to Follow the Progress of These Biotechs.NEWS2: 6 Guru Stocks Beating the Market.NEWS3: Novo Nordisk's Semaglutide in Tablet Form Gets FDA Approval.NEWS4: SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Novartis AG.
2019-09-24: NEWS1: Novartis Securities Investment Ltd -- Moody's announces completion of a periodic review of ratings of Novartis AG.NEWS2: UPDATE 2-Novartis blames former AveXis executives for Zolgensma data manipulation.NEWS3: Bristol-Myers Squibb Company -- Moody's: China's rising demand for drugs will fuel foreign pharma companies' growth into 2023.NEWS4: Biogen's Two MS Drugs Get CHMP Nod for Use in Pregnancy.NEWS5: Novartis blames former AveXis executives for Zolgensma data manipulation.NEWS6: Novartis blames former Avexis executives for Zolgensma manipulation.NEWS7: The Daily Biotech Pulse: Sandoz Recalls Ulcer Drug, Anchiano Strikes Agreement With ADT Pharma, Proteon Announces Reverse Merger.NEWS8: LabCentral co-founder issues ‘call to action' to biotechs on drug pricing.
2019-09-25: NEWS1: ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm.NEWS2: Rossini S.a r.l -- Moody's announces completion of a periodic review of ratings of Rossini S.a r.l.NEWS3: Bristol-Myers Squibb Company -- Moody's: China's rising demand for drugs will fuel foreign pharma companies' growth into 2023.

Answer: Rise